Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood…
By Virend K. Somers, D. White, R. Amin, W. Abraham, F. Costa, A. Culebras, S. Daniels, J. Floras, C. Hunt, L. Olson and 4 more. Journal of the American College of Cardiology, 2008
1,479 citations recorded by the source corpus.
Subfields: Cognitive Neuroscience, Endocrine and Autonomic Systems, Physiology
View Paper: https://www.semanticscholar.org/paper/0c607f5564ab197d8a827e41c1d14659c0a76a4c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cognitive Neuroscience
In Endocrine and Autonomic Systems
In Physiology
- I. Graham
- Massimo F. Piepoli
- T. Ivanova
- Anne B. Newman
- Naresh M. Punjabi
- D. Gottlieb
- Helaine E. Resnick
- G. Semenza
Citations in the corpus
- Sleep-Disordered Breathing and Mortality: A Prospective Cohort Study (2009, background): “A number of studies over the last decade, including the Sleep Heart Health Study [23,24], have shown that sleep-disordered breathing is associated with hypertension, CAD, congestive heart failure, and stroke [22].”
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2016, background): “Continuous positive airway pressure is the gold-standard therapy and reduces CV mortality and events.(183)”
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice. (2016, background): “Continuous positive airway pressure is the gold-standard therapy and reduces CV mortality and events.(183)”
- Clinical Prediction Models for Sleep Apnea: The Importance of Medical History over Symptoms (2016, neutral): “3,22,23 29 Improving the accuracy of screening tools is important to address underdiagnosis.”
- ADAPTIVE AND MALADAPTIVE CARDIORESPIRATORY RESPONSES TO CONTINUOUS AND INTERMITTENT HYPOXIA MEDIATED BY HYPOXIA-INDUCIBLE FACTORS 1 AND 2 (2012, background): “Recurrent apnea patients are prone to develop systemic hypertension (241, 304, 315) and exhibit elevated sympathetic nerve activity, enhanced sympathetic nerve response to acute hypoxia, as well as elevated plasma and urinary catecholamines (4, 97, 151).”
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2017, positive): “Continuous positive airway pressure is the gold-standard therapy and reduces CV mortality and events [183].”
- Association Between Treated and Untreated Obstructive Sleep Apnea and Risk of Hypertension (2012, neutral): “Hyperlipidemia 28 (9) 30 (11) 26 (14) 8 (14) 21 (15) 31 (13) 94 (16)”